Total Payments
$4,394
2024 Payments
$276.55
Companies
25
Transactions
259
Medicare Patients
1,912
Medicare Billing
$287,134
Payment Breakdown by Category
Food & Beverage$4,375 (99.6%)
Education$19.08 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,375 | 257 | 99.6% |
| Education | $19.08 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $913.32 | 61 | $0 (2024) |
| UCB, Inc. | $742.50 | 52 | $0 (2024) |
| Biogen, Inc. | $619.90 | 33 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $460.71 | 11 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $375.07 | 29 | $0 (2021) |
| Allergan, Inc. | $252.68 | 26 | $0 (2020) |
| AbbVie Inc. | $150.98 | 9 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $117.75 | 1 | $0 (2018) |
| Lilly USA, LLC | $88.20 | 4 | $0 (2023) |
| GENZYME CORPORATION | $85.64 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $276.55 | 18 | Novartis Pharmaceuticals Corporation ($157.71) |
| 2023 | $631.92 | 34 | Novartis Pharmaceuticals Corporation ($358.59) |
| 2022 | $603.84 | 35 | Novartis Pharmaceuticals Corporation ($275.42) |
| 2021 | $251.49 | 16 | AbbVie Inc. ($80.30) |
| 2020 | $221.11 | 11 | Allergan, Inc. ($65.27) |
| 2019 | $429.80 | 36 | UCB, Inc. ($140.05) |
| 2018 | $874.31 | 41 | ACADIA Pharmaceuticals Inc ($229.13) |
| 2017 | $1,105 | 68 | UCB, Inc. ($307.48) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Neurology | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: Neurology | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Neurology | ||||||
| 06/28/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: Neurology | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Neurology | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: Neurology | ||||||
| 05/07/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROLOGY | ||||||
| 05/02/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Neurology | ||||||
| 05/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Neurology | ||||||
| 04/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Neurology | ||||||
| 02/29/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Rare Disease | ||||||
| 02/27/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: Neurology | ||||||
| 02/09/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Neurology | ||||||
| 02/09/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Neurology | ||||||
| 02/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Neurology | ||||||
| 01/23/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: Neurology | ||||||
| 01/10/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Neurology | ||||||
| 01/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Neurology | ||||||
| 12/19/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $17.35 | General |
| 12/12/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Neurology | ||||||
| 11/27/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Neurology | ||||||
| 11/09/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $10.22 | General |
| Category: Neurology | ||||||
| 10/23/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Neurology | ||||||
| 10/19/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.60 | General |
| Category: Neuroscience | ||||||
| 09/28/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,405 | 1,498 | $332,576 | $193,460 |
| 2022 | 2 | 153 | 253 | $85,410 | $30,132 |
| 2021 | 3 | 173 | 290 | $79,988 | $34,906 |
| 2020 | 4 | 181 | 298 | $81,750 | $28,635 |
Total Patients
1,912
Total Services
2,339
Medicare Billing
$287,134
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95925 | Placement of skin electrodes and measurement of stimulated sites in arms | Office | 2023 | 321 | 321 | $80,250 | $52,805 | 65.8% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 162 | 162 | $48,600 | $30,293 | 62.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 321 | 321 | $38,520 | $28,226 | 73.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 93 | 93 | $32,550 | $20,381 | 62.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 322 | 322 | $38,640 | $20,303 | 52.5% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 66 | 66 | $23,100 | $16,679 | 72.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 162 | $46,104 | $16,037 | 34.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 51 | 51 | $24,812 | $8,737 | 35.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 188 | $53,758 | $18,788 | 34.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 65 | 65 | $31,653 | $11,344 | 35.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 215 | $49,231 | $21,907 | 44.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 55 | 55 | $23,749 | $10,042 | 42.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $7,008 | $2,957 | 42.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 104 | 221 | $48,599 | $17,335 | 35.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 51 | 51 | $21,369 | $8,385 | 39.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $4,906 | $2,016 | 41.1% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2020 | 12 | 12 | $6,876 | $898.63 | 13.1% |
About Dr. David Edelman, MD
Dr. David Edelman, MD is a Neurology healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366482960.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Edelman, MD has received a total of $4,394 in payments from pharmaceutical and medical device companies, with $276.55 received in 2024. These payments were reported across 259 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,375).
As a Medicare-enrolled provider, Edelman has provided services to 1,912 Medicare beneficiaries, totaling 2,339 services with total Medicare billing of $287,134. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Torrance, CA
- Active Since 06/08/2006
- Last Updated 08/07/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1366482960
Products in Payments
- KESIMPTA (Drug) $829.84
- Briviact (Drug) $490.57
- NUPLAZID (Drug) $460.71
- APTIOM (Drug) $375.07
- VUMERITY (Drug) $261.67
- TYSABRI (Biological) $245.62
- NAMZARIC (Drug) $129.42
- VRAYLAR (Drug) $122.50
- INGREZZA (Drug) $117.75
- TECFIDERA (Drug) $112.61
- Vimpat (Drug) $103.19
- UBRELVY (Drug) $94.37
- AMYVID (Drug) $88.20
- AUBAGIO (Drug) $85.64
- ACTIVA (Device) $71.17
- ZEPOSIA (Drug) $65.90
- Rystiggo (Drug) $58.09
- Neupro (Drug) $56.24
- QULIPTA (Drug) $53.18
- GILENYA (Drug) $51.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Torrance
Dr. Jason Tarpley, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $21,061
Neurology $21,061
Dr. Han Lee, M.d, M.D
Neurology — Payments: $20,140
Neurology $20,140
Dr. Monquen Huang, M.d, M.D
Neurology — Payments: $13,412
Neurology $13,412
Jeffrey Kim, M.d, M.D
Neurology — Payments: $11,411
Neurology $11,411
Ben Tseng, M.d, M.D
Neurology — Payments: $10,277
Neurology $10,277
Kevin Kapur, M.d, M.D
Neurology — Payments: $5,145
Neurology $5,145